Can someone explain me why after some months of not using X, suddenly I have fake-looking Trump & Musk supporters following me 🤮? I might close X @elonmusk

📢 Stay in the loop with #EASIGEN-DS newsletter! Our newsletter is launching soon, make sure you receive updates on the project and take a sneak peak of what's coming soon! Subscribe here➡️ https://t.co/JOjkjTCrUm #EASIGEN-DS #ResearchInfrastructure #HorizonEU

📣 My new paper is online! 🦠 🔥Straight from the oven🔥 9 April 2025 😎 🤓 It's not much, but it's honest work 💅 #HPV #Splicing #alternativesplicing #virus #cervicalcancer @PLOSPathogens @IPVSociety @VirologyJ @CVRinfo https://t.co/UwooIvwxUF

Meet @LiddelowSA, a neuroscientist at NYU Langone Health who is using the new Illumina Single Cell 3’ Prep to investigate a challenging target: astrocytes. With the flexibility of our new technology, the team can sequence 2,000 cells just as easily as 200,000—and it allows them

🧬🤓 A pleasure to attend today to the Belgian Society of Medical Oncology Meeting 2025 @mybsmo #BSMO2025 at Brugge #oncology #precisionmedicine #diagnostics #NGS

Enfortumab vedotin and stereotactic radiation tested before surgery in #MIBC in the STAR-EV trial. @TiansterZhang @UTSWMedCenter joins @l_ballas @CedarsSinai to discuss the combination of EV and radiation for cisplatin-ineligible muscle-invasive bladder cancer patients. The study

Researchers from the CME @UZLeuven @KU_Leuven developed a new technique that combines #genetic and #epigenetic analyses. This opens the door to faster diagnosis and more insight into the cause of #rarediseases. Covered in the national news 👇 https://t.co/IQqW0KQg29

Accelerating AI adoption to improve Genomic Medicine #NHSGenomics2024

Christos Vaklavas maps the path of development of novel agents targeting PIK3CA and discusses phase 1 results of RLY-2608, STX-478 and LOXO-783 #SABCS24 @OncoAlert

📌“Optimizing outcomes for HER2-expressing breast cancer through novel biomarkers and TKIs” Great discussion by @PTarantinoMD 👏🏻 #SABCS24 #day3 @OncoAlert #OncoAlertAF @DFCI_BreastOnc

https://t.co/yQ8R9Z1A0X

🔴 The new episode of our posdact "Beating Cancer Belgium" is out! This third episode is discussing on the evolving role of #telemedicine in #cancer care and control. This @sciensano podcast is created by the Belgian 'EBCP' mirror group initiative. 🎧 https://t.co/74uBpfx8zu

To have a bit fun.. I generated this one.. :) To many more adventures ! 5/5

#DRAGEN @illumina method fully described & benchmarked out in @NatureBiotech: https://t.co/6LHDdqJkI1 Graph genome based detection of SNV, STR, SV, CNV all in 30 min! Improvements in all variants! Huge thanks to @SCatreux @mehio_rami @srbehera11 @BCM_HGSC #Bioinformatics 1/5

Ready for #ISER2024 @iserworld in Buenos Aires! @ugent_fge @ugent_fwe @RAREMED1 will be represented well by @eva_dhaene @mburcucicekdal @CoppietersF Bart Leroy @elfridedebaere More info about our talks and sessions will follow!

Hello!

i'm monitoring a few genomics chat groups and it's funny but I think the whole genomics community tuned in for that @illumina . congratulations

Meet the MiSeq i100 Series – the new standard in sequencing simplicity. With 3-step setup, onboard DRAGEN analysis, and same-day results, what will you discover next? https://t.co/AeYn4ck9NP

Edinburgh Genomics staff staying late to hear the exciting @illumina announcements about MiSeq i100! #sequencing #illumina #Genomics #NGS #nextgeneration

Medical equipment maker Illumina on Wednesday announced its new series of smaller, low-cost benchtop gene sequencers, a move that will make sequencing accessible to more research and testing labs. https://t.co/O6lRKUvte3